retatrutide ema approval approval: FDA status, clinical trial results, and when it could be available Eli Lilly's Retatrutide Shows Promise

The medication typically shows a significant reduction in blood sugar levels and improves glycemic control when you use the medication at FDA-approved therapeutic doses (such as 2.5 mg, 5 mg, 10 mg, 12.5 mg, and 15 mg)

Zhang Y, Parajuli KR, Fava GE, et al

Additionally, GLP-1 signaling influences calcitonin gene-related peptide (CGRP), a neuropeptide strongly implicated in migraine pathophysiologythe same target that newer migraine-specific medications like erenumab address

At the tissue level, GLP-1 agonists diminish ectopic fat accumulation in the liver and muscle, enhancing insulin sensitivity

Ultimately discussing these factors with your healthcare provider will ensure you select the most suitable option for your diabetes management journey